Sofia Leo

1 Introduction Chemoradiation therapy (CRT) remains on the forefront of cancer care, playing a critical role in preventing disease recurrence in surgically resected tumors and extending the survival of inoperable patients.[1-3] For patients with locally advanced pancreatic ductal adenocarcinoma (PDAC), CRT with multi-agent chemotherapy such as FOLFIRINOX (folinic acid, fluorouracil, irinotecan, oxaliplatin) is one of the most effective treatment regimens, albeit with an overall survival of...